Perseus Proteomics Inc. (TYO:4882)
Japan · Delayed Price · Currency is JPY 143.00
+1.00 (0.70%)
Jul 30, 2026, 3:30 PM JST
Perseus Proteomics Market Cap
Perseus Proteomics has a market cap or net worth of 2.62 billion as of July 29, 2026. Its market cap has decreased by -56.19% in one year.
Market Cap
2.62B
Enterprise Value
1.10B
Revenue
135.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
143.00
ChartMarket Cap Chart
Since June 22, 2021, Perseus Proteomics's market cap has decreased from 10.12B to 2.62B, a decrease of -74.14%. That is a compound annual growth rate of -23.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 2.62B | -20.79% |
| Dec 30, 2025 | 3.30B | -60.12% |
| Dec 30, 2024 | 8.28B | 13.70% |
| Dec 29, 2023 | 7.29B | 97.33% |
| Dec 30, 2022 | 3.69B | -20.91% |
| Dec 30, 2021 | 4.67B | -53.87% |
| Jun 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.20T |
| Otsuka Holdings | 5.86T |
| Daiichi Sankyo Company | 5.01T |
| Astellas Pharma | 3.88T |
| Kyowa Kirin | 1.37T |
| Ono Pharmaceutical | 1.14T |
| Santen Pharmaceutical | 634.85B |
| JCR Pharmaceuticals | 63.08B |